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Abstract
The dosage compensation complex (DCC) binds to single X chromosomes in Drosophila males and increases the
transcription level of X-linked genes by approximately twofold. Male-specific lethal 2 (MSL2) together with MSL1 mediates
the initial recruitment of the DCC to high-affinity sites in the X chromosome. MSL2 contains a DNA-binding cysteine-rich
CXC domain that is important for X targeting. In this study, we determined the solution structure of MSL2 CXC domain by
NMR spectroscopy. We identified three zinc ions in the CXC domain and determined the metal-to-cysteine connectivities
from
1H-
113Cd correlation experiments. The structure reveals an unusual zinc-cysteine cluster composed of three zinc ions
coordinated by six terminal and three bridging cysteines. The CXC domain exhibits unexpected structural homology to pre-
SET motifs of histone lysine methyltransferases, expanding the distribution and structural diversity of the CXC domain
superfamily. Our findings provide novel structural insight into the evolution and function of CXC domains.
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Introduction
Organisms with different numbers of sex chromosomes between
males and females face the problem of an unequal dosage of genes
from sex chromosomes. In Drosophila melanogaster, the transcrip-
tional level of most genes in the single male X chromosome is
increased by approximately twofold to match that from two female
X chromosomes (see recent reviews [1–3]). This dosage compen-
sation process is mediated by the dosage compensation complex
(DCC) or male-specific lethal (MSL) complex, which contains at
least five proteins MSL1, MSL2, MSL3, males absent on the first
(MOF) and maleless (MLE) and two non-coding RNAs roX1 and
roX2. MSL1 is a scaffold protein associated with MSL2, MSL3
and MOF [4–6].
In male flies, the DCC is located at hundreds of sites along the
length of the X chromosome. Each of five proteins and at least one
of the functionally redundant roX RNAs are required for full
association of the DCC on the X chromosome and for male
viability. The DCC is not assembled in females because MSL2
translation is tightly repressed [7,8]. The DCC has been shown to
primarily bind at bodies of active genes on the X chromosome
[9,10]. The transcriptional activation is caused, at least in part, by
the MOF-mediated acetylation of histone H4 lysine 16 and
enhanced transcriptional elongation [11].
The mechanism by which the DCC is specifically localized to
the X chromosome remains poorly understood. According to
a prevalent model, the DCC first binds to a limited number of
high-affinity sites (HAS) or chromatin entry sites (CES) in the X
chromosome and then spreads in cis to flanking active genes [12].
The spreading process probably involves the interaction of the
MSL3 chromodomain with trimethylated H3K36, a marker for
actively transcribed genes [13]. HAS are able to attract even
a partially assembled DCC that lacks MSL3, MOF or MLE, or
a low concentration of DCC [7,14,15]. A body of evidence
suggests that specific DNA sequences are involved in HAS
recognition. When translocated to an autosome, HAS as short as
100–200 base pairs (bp) can still recruit the DCC [16–20].
Chromatin immunoprecipitation studies followed by microarray
analysis or deep sequencing have mapped ,140 HAS on the X
chromosome [20,21]. The binding sites of the DCC on HAS are
enriched with a GA-rich MSL recognition element (MRE) [20].
However, the MRE motif occurs frequently outside of HAS and is
only slightly enriched in the X chromosome over autosomes,
indicating that the MRE motif is not the sole determinant for HAS
recognition. The conformation of chromatin also appears to be
important for HAS recognition, since HAS are characterized by
low nucleosome occupancy [20] and special compartments in the
nuclei [22].
MSL2 is a core component of the DCC [23–25] and together
with MSL1 is required for the DCC to bind HAS on the X
[14,15,26,27]. MSL2 was recently shown to be a DNA-binding
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Drosophila cells [28]. However, MSL2 failed to discriminate the
HAS sequence in vitro. An unknown selectivity cofactor was
proposed to cooperate with MSL2 in vivo for specific HAS
recognition [28].
MSL2 is composed of an N-terminal RING domain, a cysteine-
rich CXC domain and a C-terminal region rich in proline and
basic residues (Pro/Bas patch). The RING domain binds MSL1
[6,29] and exhibits ubiquitin E3 ligase activity toward H2B K34
[30]. The CXC domain contributes critically to the DNA-binding
activity of MSL2 [28]. CXC domains are also present, mostly in
two copies, in the tesmin/TSO1 protein family [31–35]. The
tandem CXC domain of human LIN54 and soybean CPP1 has
been shown to bind specific DNA sequences [32,33]. No structure
has been reported for any CXC domain.
The CXC domain is remarkable by having 9 invariant Cys
within about 50 residue region. In this study, we have determined
the first structure of MSL2 CXC domain by NMR spectroscopy.
The structure reveals a compact fold that encages an unusual
Zn3Cys9 cluster. Interestingly, the CXC structure with a Zn3Cys9
cluster shows strong similarity to pre-SET motifs of histone lysine
methyltransferases, suggesting that the CXC and pre-SET
domains share a common evolutionary origin.
Results
The MSL2 CXC Domain is an Autonomously Folded
Structure Containing Three Zinc Ions
Our structural analysis of D. melanogaster MSL2 CXC domain
was conducted mainly on two constructs. One construct contain-
ing residues 517–572 and the C560G mutation (CXC-2) was used
in early experiments, and another slightly shorter construct
containing residues 520–570 and the C560G mutation (CXC-3)
was used in the majority of experiments. The two fragments
display identical NMR spectra in folded regions and thus should
have the same structure. In both constructs, the nonconserved
residue Cys560 was replaced by glycine, an amino acid that is
frequently found at the corresponding position in MLS2 homo-
logs, to avoid formation of intermolecular disulfide bonds. The
1H-
15N HSQC spectrum of the MSL2 CXC domain displays
a single set of well-dispersed peaks, indicating that the fragment is
autonomously folded and amenable for further structural charac-
terization (Fig. 1A). Nearly complete assignments for backbone
and side-chain resonances were obtained by analysis of a set of
triple-resonance spectra collected on
13C/
15N-labeled CXC
protein.
The CXC domain is characterized by nine invariant cysteine
residues and conserved spacing between them, suggesting that
these cysteine residues may coordinate metal ions. Indeed,
inductively coupled plasma mass spectrometry of recombinant
CXC protein revealed a significant enrichment of Zn compared
with other metals Fe, Mg, Ca, Mn, Ni and Cu (data not shown).
To assess the Zn binding stoichiometry, the CXC-3 protein was
analyzed with electrospray mass spectroscopy under conditions
that preserve the native protein structure (Fig. 1B). The
monoisotopic mass of the major species (5824.0875 Da) precisely
matched that of a monomeric CXC-3 molecule in complex with
three Zn
2+ ions (5824.267 Da). Analytical ultracentrifuge sedi-
mentation velocity assay further showed that the CXC domain is
a monomer in solution (data not shown). These biophysical results
indicate that the CXC domain folds into a monomeric structure
with three bound zinc ions.
Assignment of Zn-coordinating Ligands by
113Cd NMR
Three Zn
2+ ions are most likely coordinated by nine invariant
Cys residues in the MLS2 CXC domain. The CXC domain has
two histidines at positions 557 and 565, but they are not conserved
and are unlikely to bind structurally important Zn
2+ ions. As each
Zn
2+ ion needs to be coordinated to four ligands, the unusual Zn
to Cys ratio of 3:9 suggests that these Zn
2+ ions are bound in an
unconventional way. To assign the zinc ligands, we replaced Zn
with
113Cd, which has a similar coordination pattern to Zn but has
more favorable NMR properties [36]. The
113Cd-loaded protein
was prepared during protein expression by substituting Zn
2+ with
113Cd
2+ in minimal M9 medium.
The
1H-
15N HSQC spectrum of
113Cd/
15N-labeled CXC
protein displays a single set of peaks, indicating complete
113Cd
substitution (Fig. 2A). As many resonances were shifted after
113Cd replacement, the resonances of H, N, Ha and Hb were
reassigned using 3D
1H-
15N TOCSY-HSQC and 3D
1H-
15N
NOESY-HSQC spectra collected on
113Cd/
15N-labeled protein.
The amide resonances of Cys residues and nearby residues
generally display large changes upon
113Cd replacement
(Fig. 2B). The chemical shifts of Ha and Hb protons are less
affected, with an average deviation of 0.048 ppm and a maximal
deviation of ,0.38 ppm. The NOE patterns are unaltered,
indicating that the structure is minimally disturbed by
113Cd
substitution.
The
1H-decoupled 1D
113Cd spectrum shows three peaks at
734.2, 740.2 and 746.6 ppm (Fig. 3A), in agreement with three
Zn
2+ ions identified by native electrospray mass spectroscopy.
These peaks appear as triplets but are most obvious for Cd-A.
Each
113Cd ion is probably coupled to the other two
113Cd ions
by sharing a bridging cysteine ligand, and the
113Cd-
113Cd two-
bond couplings (
2JCd-Cd ,30 Hz) split these resonances into
triplets.
We collected a series of 2D
1H-
113Cd HSQC spectra and an
HMQC-TOCSY spectrum to correlate
113Cd ions to Hb and
Ha protons of coordinating Cys residues (Fig. 3C-F). Some Cys
Hb protons have close chemical shift values, hindering
assignment of
113Cd coordination. To measure
1H chemical
shifts with higher precision, we collected a 2D
1H-
15N HSQC-
TOCSY spectrum, in which
1H resonances were recorded in
the more resolved direct dimension and could be directly
aligned to
1H-
113Cd HSQC spectra (Fig. 3B). Analysis of these
spectra revealed that Cd-A (734.2 ppm) is coordinated to
Cys525, Cys527, Cys539 and Cys544, Cd-B (740.2 ppm) to
Cys525, Cys546, Cys553 and Cys556, and Cd-C (746.6 ppm) to
Cys558 and Cys561. The other two ligands for Cd-C were
missing in all spectra probably due to small
3JHb-Cd value and
could not be assigned.
Structural Determination of MSL2 CXC Domain
The structure of MSL2 CXC domain was initially calculated in
CYANA based solely on autoassigned NOE cross-peaks without
incorporation of zinc ions. The resulting structures converged and
showed a compact fold with Cys clustering at the center. The
structure was further refined in CNS with additional TALOS-
derived dihedral restraints, protein-zinc restraints deduced from
113Cd NMR and explicit water (see Materials and Methods).
Inspection of structures calculated without the Zn-C restraints
suggested that Cys539 and Cys553 are the remaining two ligands
for Zn-C that could not be identified with
113Cd NMR. Other
assignments of Zn-C ligands were not consistent with the existing
structural restraints. The numbers and types of restraints used in
the final structure calculation and the statistics for the 20 lowest
energy structures are given in Table 1.
Structure of MSL2 CXC Domain
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restraints per residue. The root mean square deviation (RMSD)
values of the 20 best structures to the mean structure are 0.38 A ˚
and 0.87 A ˚ for backbone and heavy atoms in the structure core
(residues 523–529 and 538–565), respectively (Fig. 4A). A few
terminal residues and an internal loop (residues 530–537) are
poorly defined in the structure because of a lack of long-range
distance restraints. These residues are intrinsically dynamic on the
ps-ns timescale, as evidenced by their reduced steady-state
1H-
15N
heteronuclear NOE values (Fig. 4B).
The Solution Structure of MSL2 CXC Domain
The CXC domain adopts a small globular fold that encapsu-
lates three triangularly arranged zinc ions (Fig. 5B). Among nine
Cys ligands, six are singly coordinated, and three (Cys525, Cys539
and Cys553) simultaneously bind two zinc ions, such that each
zinc ion is tetrahedrally coordinated to two terminal and two
bridging Cys. The structure is composed of two loops that wrap
around the Zn3Cys9 cluster in a right-handed manner. The N-
terminal loop (residues 521–550) including a short a-helix (residues
Figure 1. The CXC domain of MSL2 binds three zinc ions. (A)
1H-
15N HSQC spectrum of the CXC domain. The spectrum was collected on 1 mM
15N-labeled CXC-3 protein in 50 mM phosphate buffer (pH 6.0) and 10%
2H2Oa t2 5 uC and 600 MHz. The assigned residues are labeled with full-
length MSL2 numbering, and the side-chain amide protons are connected by lines. (B) Electrospray ionization mass spectroscopy reveals three bound
Zn
2+ ions. The CXC-3 protein was exchanged into 200 mM ammonia acetate and analyzed with a Q-Star instrument. The inset shows the major
isotopic peak series from a +5 charge species. The monoisotopic peak (m/z 1165.8361) corresponds to an exact mass of 5824.1805 Da, consistent with
a complex of CXC-3 and three Zn
2+ ions (monoisotopic MW=5824.267 Da). The peak series around m/z=1460 originates from a +4 charge species.
doi:10.1371/journal.pone.0045437.g001
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(residues 551–567) contains four Cys residues.
An intact Zn3Cys9 cluster appears to be important for the
structure and function of CXC domains. The Ala double
substitution of Cys544 and Cys546 of MSL2 was previously
shown to delay development and reduce male fly viability [14].
The same double mutation impaired the DNA-binding ability of
MSL2 and abolished its targeting to an HAS in D. melanogaster cells
[28]. According to our structure, these two Cys residues are the
ligand for Zn-A and Zn-B, respectively. The mutation likely
disrupts the CXC domain structure, hence impairing its DNA-
binding activity and in vivo function. In addition, Cys mutations in
the CXC domain were shown to disrupt the function of TSO1 in
flower development and cell division [34] and to impair the DNA-
binding activity of human LIN54 [32].
Besides invariant Cys ligands, residues Arg526, Gly528,
Thr538, Arg543, Try547 and Asn563 are also highly conserved
among MSL2 homologs (Fig. 5A). These residues could be
conserved for structural and/or functional reasons. In the
structure, the side chains of Thr538 and Asn563 form hydrogen
bonds with the carbonyl oxygen atoms of Gly560 and Asn551,
respectively (Fig. 5C). These long range interactions apparently
stabilize the small fold. The aromatic ring of Try747 is partially
buried and Gly528 is located in a b-turn; these two residues
probably also play a structural role. The Ala mutation of Try547
has been shown to disrupt the DNA binding and HAS targeting of
MSL2 [28]. By contrast, the conserved Arg526 and Arg543 are
solvent exposed and they together with other less conserved basic
residues constitute a negatively charged surface patch (Fig. 5D).
The two conserved arginine residues probably contribute to the
function of CXC domain, such as DNA interaction.
To validate the structure, we conducted proton-deuterium
exchange experiment. The lyophilized CXC protein was dissolved
in
2H2O and monitored with
1H-
15N HSQC spectra for
disappearance of amide proton. Seventeen amide protons were
observed in the first recorded spectrum, ten persisted after 2 h and
four remained after 24 h (Fig. 6A–D). According to our structure,
these slow exchange amide protons are generally involved in
hydrogen binding or are buried, and hence are protected from
solvent exchange (Fig. 6E). In particular, the two side chain amide
protons of Asn563, but not from other Asn or Gln, were protected,
supporting that they are hydrogen bonded (Fig. 5C).
Structural Similarity between CXC and Pre-SET Domains
Similar Zn3Cys9 clusters have been previously described in
metallothioneins (MTs) and the SUV39 family of SET domain
histone lysine methyltransferases (HKMTs). MTs are ubiquitous
Cys-rich small proteins (6–7 kDa) with a high content of divalent
metal ions such as Zn
2+,C d
2+ and Cu
1+ and are involved in metal
homeostasis, detoxification and protection against reactive oxygen
[37]. The mammalian MT II is composed of a b-domain that
binds an M3Cys9 metal-thiolate cluster and an a-domain that
binds an M4Cys11 cluster [38]. M3Cys9 clusters are also present in
other families of MTs [39–41]. However, the structural fold and
linear order of Cys ligands in MSL2 CXC domain are distinct
from those in various types of structurally characterized MTs [38–
41]. MTs and CXC domains are also unrelated in function.
Surprisingly, the CXC domain structure shows remarkable
resemblance with structures of pre-SET motifs in the SUV39
family of HKMTs [42–44]. SET domain HKMTs have been
classified into at least seven families, and the SET domains of
SUV39, SET2 and EZ family proteins are preceded by a family-
specific Cys-rich pre-SET motif [45].
Structures of SUV39 family HKMTs show that the pre-SET
domain coordinates three zinc ions with nine invariant Cys
residues [42–44]. Like the MSL2 CXC domain, the zinc-
binding structure of SUV39 pre-SET domains is composed of
two loops with five and four Cys residues (Fig. 7A,B).
Importantly, the linear order of Cys ligands for each of three
zinc ions are strictly conserved between MSL2 CXC and
SUV39 pre-SET domains (Fig. 7D). The spacing of Cys
normally varies within two residues except in two regions. First,
the SUV39 pre-SET domains contain an insertion of 25–60
residues between Cys-5 and Cys-6 that interacts with the SET
domain. Second, the segment between Cys-2 and Cys-3 is
longer in MSL2 CXC domain (11 residues) than that in SUV39
pre-SET domains (2–5 residues).
The unexpected structural similarity of SUV39 pre-SET
domains and the CXC domain led us to examine whether other
pre-SET motifs are related to the CXC domain. Several crystal
structures have been recently determined for SET2 family
HKMTs ([46,47] and PDB 3H6L). These structures show that
the pre-SET motif of SET2 proteins, which is also known as
associated with SET domain (AWS), contains a Zn2Cys7 cluster
(Fig. 7C). Despite having a different ZnCys cluster, the zinc-
binding structure of the SET2 pre-SET domain bears significant
similarity to the SUV39 pre-SET and CXC structures. The
SET2 pre-SET domain can be considered a CXC domain
variant that has a similar binding mode for Zn-A and Zn-C but
that loses binding of Zn-B because of the absence of Cys-5 and
Cys-7 equivalents (Fig. 7D). Cys-3 still bridges Zn-A and Zn-C
as in CXC and SUV39 pre-SET structures.
No structure is currently available for the EZ family HKMTs.
The EZ pre-SET motif contains 17 invariant Cys residues
within about an 80-residue region. Some sequence similarity has
been noted between the CXC and EZ pre-SET domains
[31,33–35]. In fact, the name of ‘‘CXC domain’’ was originally
coined to describe the pre-SET motif of EZ proteins [48] and
later adopted to designate the Cys-rich regions in TSO1 and
MSL2 proteins [31,35]. A single CXC domain was previously
identified in the EZ pre-SET, but it lacks an equivalent of Cys-
7 [31]. In considering the structural restraints that nine ligands
are required for binding three zinc ions, we revised the
alignment and identified two CXC domains in EZ pre-SET
(Fig. 7D). In this new alignment, the second ligand of the N-
terminal CXC domain is His, which is invariant in EZ pre-
SET, rather than Cys. Histidine has been shown to coordinate
zinc clusters as a terminal ligand [49]. The tandem CXC
domains of EZ pre-SET are immediately adjacent to each other
in contrast with those found in tesmin/TSO1 proteins, which
are separated by 40–60 residues.
We found that the second position C-terminal of Cys-9 is always
occupied by an Asn residue in CXC and three types of pre-SET
domains (Fig. 7D). In the crystal structures of SUV39 and SET2
Figure 2. Chemical shift perturbation by
113Cd substitution. (A) Superimposed
1H-
15N HSQC spectra of Zn-loaded (black) and
113Cd-loaded
(red) CXC-3 proteins. Assignments are indicated for Zn-CXC. The distantly separated peak pairs are connected by red lines. The
113Cd-CXC
assignments were confirmed with 3D
1H-
15N TOCSY-HSQC and 3D
1H-
15N NOESY-HSQC spectra collected on
113Cd/
15N-labeled protein. (B) Chemical
shift changes of the amide protons and nitrogens between
113Cd- and Zn-loaded CXC-3 proteins. Cys and non-Cys residues are shown with filled and
empty bars. Dd
1H=d
1HCd-CXC-d
1HZn-CXC, Dd
15N=d
15NCd-CXC-d
15NZn-CXC.
doi:10.1371/journal.pone.0045437.g002
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stabilizing the conformation of the C-terminal loop with its side
chain amide nitrogen making a hydrogen bond to the carbonyl
oxygen of the second residue N-terminal of Cys-6 (Fig. 7B, C). In
the NMR structure of MSL2 CXC domain, the Asn side chain
makes a similar interaction with the polypeptide backbone
(Fig. 7A). The C-terminal Asn is also invariant in the CXC
domains of tesmin/TSO1 proteins and the two reassigned CXC
domains of EZ pre-SET. These findings indicate that the C-
terminal Asn is a signature residue of the CXC superfamily.
In summary, we show that three types of pre-SET motifs are all
related to the CXC domain. SUV39 pre-SET is a CXC domain
with a large insertion, SET2 pre-SET is a variant CXC domain
lacking one zinc ion and EZ pre-SET appears to contain tandem
CXC domains. We can define the consensus sequence of CXC
superfamily as CX[C/H]X2–13CX4–7CXCX5–60CX2–4CX1–
2CX2–15CXN.
Figure 3. NMR spectra of
113Cd/
15N-labeled CXC-3 protein. (A) 1D
1H-decoupled
113Cd spectrum. (B) 2D
1H-
15N HSQC-TOCSY spectrum. The
Cys residues at positions 525, 527, 539, 544, 546, 553, 556, 558 and 561 are sequentially numbered from 1 to 9. Cross-peaks originating from Cys Hb
are labeled with the residue number and dash-separated sequential number of Cys, and cross-peaks from Cys Ha are additionally marked with ‘‘a’’.
The spectrum is divided by a vertical line into two parts. The left Ha region is shown with a higher contour level than the right Hb region for clarity.
Some peaks from Cys527 and Cys561 marked by squares are not visible, and their positions were inferred from a 2D
1H-
15N HSQC-NOESY spectrum.
(C)
1H-
113Cd HMQC-TOCSY spectra with
3JHB-Cd set to 50 Hz and a mixing time of 30 ms. (D-F)
1H-
113Cd HSQC spectra with
3JHB-Cd set to 20 Hz (D),
30 Hz (E) and 50 Hz (F). Assigned cross-peaks are marked with sequential number of Cys and those peaks from Ha are additionally labeled with ‘‘a’’.
doi:10.1371/journal.pone.0045437.g003
Table 1. Refinement statistics for the 20 lowest energy NMR structures of MSL2 CXC domain.
Restraint statistics
Distance restraints
Total NOE 1322
Intra-residue 407
Sequential (|i – j|=1) 269
Medium-range (|i – j| #4) 111
Long-range (|i – j| $5) 160
Ambiguous 375
Total dihedral angle restraints 56
w 28
y 28
Structure statistics
Violations
Max. dihedral angle violation (u) 4.88
Max. Distance constraint violation (A ˚) 0.151
Deviations from idealized geometry
Bond lengths (A ˚) 0.010960.0004
Bond angles (u) 1.18360.044
Impropers (u) 1.58860.107
RMSD of all structures to mean (A ˚)
Heavy (residues 523–529 and 538–565) 0.8760.07
Backbone (residues 523–529 and 538–565) 0.3860.06
Ramachandran plot analysis (all residues; residues 523–529 and 538–565)
Most favored regions 77.2%; 80.7%
Additional allowed regions 21.3%; 19.3%
Generously allowed regions 0.7%; 0.0%
Disallowed regions 0.7%; 0.0%
WHAT_CHECK Z-scores (all residues; residues 523–529 and 538–565)
2nd generation packing quality 23.154; 21.963
Ramachandran plot appearance 23.153; 22.028
chi-1/chi-2 rotamer normality 21.725; 21.640
Backbone conformation 25.322; 22.954
doi:10.1371/journal.pone.0045437.t001
Structure of MSL2 CXC Domain
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The MSL1 and MSL2 complex recognizes HAS in the X
chromosome and mediates the first step of X-targeting by the
DCC. The CXC domain is the only DNA-binding domain
identified so far in the MSL1/MSL2 complex and contributes
critically to the recognition of HAS by MSL2 in vivo [28]. We
have determined the first structure of MSL2 CXC domain by
NMR spectrometry, revealing a surprising Zn3Cys9-containing
fold. The structure reveals the role of nine invariant Cys residues
in coordinating three zinc ions. The strong sequence conservation
suggests that the CXC domain of tesmin/TSO1 family proteins
should adopt a similar structure, including a Zn3Cys9 cluster, as
MSL2 CXC domain.
We have identified unexpected structural homology between
CXC and pre-SET domains, suggesting that they share a common
ancestor domain in evolution. This finding also expands the
structural diversity and distribution of the CXC domain super-
family. These deviant CXC domains have large variations in Cys
spacing, degenerate zinc binding ligands or His ligands and are
thus difficult to recognize if no structure is available. The structural
knowledge and derived consensus sequence of the CXC domain
superfamily may allow for more deviant CXC domains to be
identified.
No specific function other than a structural role has been
assigned to pre-SET domains. DNA binding appears to be the
primary function of CXC domains [28,32,33]. The homology with
the CXC domain implicates that pre-SET domains may have
a role in binding DNA, which could facilitate HKMT recognition
of nucleosomal substrates.
Many DNA-binding domains, such as helix-turn-helixes, zinc
fingers and leucine zippers, use an a-helix to contact DNA at the
major groove. The CXC structure is distinct from previously
characterized DNA-binding domains and apparently lacks such
a DNA-binding a-helix. Determining the CXC domain complex
structure with DNA will help to elucidate its likely distinct DNA-
binding mode.
Figure 4. NMR structure and dynamics of MSL2 CXC domain. (A) Structural superposition of the 20 lowest energy NMR structures. The Ca
traces of residues 521–566 and three zinc ions (spheres) are shown in cross-eye stereoview. (B) Steady-state
1H-
15N heteronuclear NOE values are
plotted as a function of residue number. The experiment was conducted for CXC-2, which contains residues 517–572 plus three extra N-terminal
residues from the vector. No data were obtained for proline residues that lack amide proton. Error bars represent the experimental uncertainties
estimated from the spectrum background noise.
doi:10.1371/journal.pone.0045437.g004
Structure of MSL2 CXC Domain
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Protein Expression and Purification
The MSL2 cDNA was obtained from the Drosophila Genomics
Resource Center. The coding sequence of the CXC domain
corresponding to residues 517–572 was amplified by PCR and
cloned into a pGEX-6p-1 vector (GE Healthcare). The mutation
C560G was introduced by QuikChange site-directed mutagenesis
(Stratagene), yielding the GST-fused CXC-2 construct. The
coding sequence consisting of residues 520–570 and the C560G
mutation was amplified from the CXC-2 plasmid and subcloned
into an engineered pET28a vector, yielding the CXC-2 construct.
The CXC-3 protein was expressed as fusion to an N-terminal
His6-SMT3 tag. Single point mutations of R526A and R543A
were introduced into CXC-3 by QuikChange. All constructs were
confirmed by DNA sequencing.
Escherichia coli Rosetta(DE3) cells containing CXC expression
vectors were grown at 37uC in LB broth. When the OD600
reached 0.8, the growth temperature was lowered to 16uC, and
the culture media was supplemented with 40 mM ZnSO4 and
0.2 mM isopropyl-b-D-thiogalactopyranoside to induce protein
expression. After additional growth for 16 h, the cells were
harvested, suspended in buffer A consisting of 50 mM Tris-HCl
(pH 8.0) and 250 mM NaCl, lysed by sonication and centri-
fuged.
The clarified lysate of GST-fused CXC-2 was loaded onto
a GSTrap column. The GST-tag was cleaved on column by
PreScission protease overnight. The released CXC-2 protein
was washed with buffer A, diluted 3-fold with 25 mM HEPES-
Figure 5. Important features of MSL2 CXC domain structure. (A) Sequence alignment of MSL2 homologs in the CXC domain. A total of 44
sequences were aligned and eight sequences are displayed. Residues conserved in 98%, 80% and 60% of 44 aligned sequences are shaded in black,
gray and light gray, respectively. Similar amino acid groups are defined as follows: D and E; S and T; K and R; F, Y and W; L, I, V and M. The secondary
structures are shown on the top with dotted line representing mobile regions. (B) Structure of the Zn3Cys9 cluster in cross-eye stereoview. The Zn-S
coordination bonds are shown as dotted lines. (C) The highly conserved non-Cys residues of MSL2 CXC domain are displayed in sticks. Two views
related by a 180u rotation are shown and dotted lines denote hydrogen bonds. (D) The electrostatic potential surface is colored from red to blue for
negatively to positively charged regions. The structure is shown in the same two orientations as in (C).
doi:10.1371/journal.pone.0045437.g005
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equilibrated in 25 mM HEPES-K (pH 7.6) and 80 mM KCl
and eluted using a linear gradient of KCl. Proteins eluting at
less than 300 mM KCl were pooled, concentrated with 3-kDa
cutoff ultrafiltration devices (Amicon) and further purified with
a Superdex 75 column in buffer 50 mM phosphate (pH 6.0).
The His6-SMT3-tagged CXC-3 protein was purified with
a HisTrap column (GE Healthcare) and eluted with 500 mM
imidazole in buffer A. The pooled factions were incubated with
ULP1 for 1 h on ice to cleave the His6-SMT3 tag. After a threefold
dilution in 25 mM HEPES-K (pH 7.6), the protein was loaded
onto a Q column. The flow-through containing CXC-3 was
further purified by heparin and gel filtration chromatography
following the same procedure as for CXC-2. Protein concentra-
tions were determined spectrophotometrically with a calculated
molar extinction coefficient of 4470 M
21 cm
21 at 280 nm for
both CXC-2 and CXC-3.
15N- or
15N/
13C- labeled CXC proteins were prepared in M9
minimal medium with 1 g/L of (
15NH4)2SO4 and, if needed, 2 g/
Lo f
13C-glucose as the sole nitrogen and carbon sources,
respectively (Cambridge Isotope Laboratories). For
113Cd labeling,
ZnCl2 in M9 media was substituted with 10 nM
113Cd acetate. E.
coli growth and protein yields were normal in
113Cd-containing
media.
Electrospray Ionization Mass Spectrometry
The CXC-3 protein was exchanged into 200 mM ammonium
acetate and analyzed by electrospray ionization mass spectrometry
with a Q-Star mass spectrometer (Applied Biosystems). To
calculate the monoisotopic mass of a species, the mass-to-charge
(m/z) ratio of its monoisotopic peak was multiplied by the charge,
and the charge was then subtracted. The monoisotopic mass of
CXC-3, which contains residues 520–570, mutation C560G and
an extra N-terminal Ser from the vector, is 5638.48 Da. The exact
mass of Zn
2+ ion was calculated as molecular mass of
64Zn
(63.929) minus 2, to compensate for two positive charges of Zn
2+
ion.
NMR Experiments
The NMR samples contained 0.5–1.5 mM CXC-2 or CXC-3
proteins, 50 mM potassium phosphate (pH 6.0), 0.01% (w/v)
sodium 2,2-dimethylsilapentane-5-sulfonate (DSS) and 10% (v/v)
2H2O. NMR data were recorded at 298 K on a Bruker
DMX600 spectrometer equipped with a triple resonance
cryoprobe, unless indicated otherwise. Three-dimensional (3D)
CBCA(CO)NH, HNCACB and HNCO spectra were collected
to obtain sequence-specific backbone resonance assignments
[50]. 3D HAHB(CO)NH, CC(CO)NH, CCH-TOCSY (mixing
time tm 12 ms), HCCH-TOCSY (tm 12 ms),
1H-
15N TOCSY-
HSQC (tm 60 ms) and 2D
1H-
13C HSQC spectra were
collected for side-chain assignments. All spectra were processed
Figure 6. Amide proton exchange experiments. (A–C)
1H-
15N HSQC spectra collected immediately (A), 2 h (B) or 24 h (C) after dissolving the
lyophilized CXC-3 protein in
2H2O. The peaks are labeled and the side chain amide proton Hd of N563 is labeled as N563D. (C) Intensity of amide
proton peak as a function of exchange time. (D) Distribution of slow exchange amide protons in the CXC domain structure. The protected amide
protons are shown as spheres on a backbone trace and are colored pink if present in the first recorded spectrum but not after 2 h, orange if present
at 2 h but not after 24 h, and red if present after 24 h. The side chain of N563 is also displayed.
doi:10.1371/journal.pone.0045437.g006
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The
1H chemical shifts were referenced to internal DSS, and
the
15N and
13C chemical shifts were referenced indirectly. The
1H-
15N steady-state heteronuclear NOE values were calculated
from the ratios of peak intensities in a
1H-
15N HSQC spectrum
collected with a 3 s period of initial proton saturation to those
in an unsaturated spectrum. The error of peak intensity was
estimated from spectrum background noise and propagated into
the error of
1H-
15N heteronuclear NOE.
In hydrogen-deuterium exchange experiments, the CXC-3
protein originally prepared in 500 ml of 50 mM potassium
phosphate (pH 6.0) was lyophilized and redissolved in 500 ml
2H2O. A series of
1H-
15N HSQC spectra were recorded 0 min,
30 min, 75 min, 120 min, 160 min, 390 min and 24 h after
sample preparation.
113Cd NMR Experiments
1D
113Cd, 2D
1H-
113Cd HSQC and 2D
1H-
113Cd HMQC-
TOCSY spectra were recorded on a Bruker 400 MHz NMR
spectrometer equipped with a broadband double resonance probe.
The delays for magnetization transfer (1/2JH-Cd) were set to 10,
16.7 and 25 ms. The resonances of
113Cd-loaded CXC were
reassigned according to the assignments of Zn-loaded CXC and
3D
1H-
15N TOCSY-HSQC and
1H-
15N NOESY-HSQC spectra
collected on
113Cd/
15N-labeled CXC protein. The
113Cd
chemical shifts are reported relative to external 1 M
Cd(CH3COO)2, which serves as the 0 ppm reference.
Structure Calculation
NOE-based distance restraints were derived from 3D
1H-
15N
NOESY-HSQC (tm 200 ms), 3D aliphatic
1H-
13C NOESY-
HSQC (tm 200 ms) and 3D aromatic
1H-
13C NOESY-HSQC (tm
200 ms) spectra. Inter-proton distances were obtained with
NMRViewJ using an exponential calibration from peak volumes
Figure 7. Structural similarity between CXC and pre-SET domains. (A) Structure of MSL2 CXC domain. The Cys ligands and the C-terminal
invariant Asn residue are shown as sticks, zinc ions as purple spheres and Zn-S coordination bonds and hydrogen bonds as dotted lines. (B) Structure
of the SUV39 family Dim5 pre-SET domain (PDB code 1ML9). The long insertion between Cys-5 and Cys-6 is shown schematically as an oval. (C)
Structure of the SET2 family NSD1 pre-SET domain (PDB code 3OOI). The three structures of MSL2 CXC, Dim5 pre-SET and NSD1 pre-SET domains are
aligned by their Zn-Cys clusters. (D) The primary sequences of MSL2 CXC domain and pre-SET motifs of Neurospora crassa Dim5, human NSD1 and
Drosophila melanogaster E(z). The observed or predicted zinc ligands are numbered sequentially from 1 to 9. The invariant C-terminal Asn is marked
with asterisk. The coordination patterns of zinc ions observed in these structures are shown. The starting and ending residues of each sequence are
labeled with residue numbers. A 48-residue region is omitted in DIM5 pre-SET. The zinc ligands in NSD1 pre-SET are numbered according to those in
the CXC domain.
doi:10.1371/journal.pone.0045437.g007
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structure was initially calculated in CYANA solely from autoas-
signed NOE peaks [52]. More than 80% of NOE peaks were
assigned this way, and the structure calculation converged with an
RMSD of 1.12 A ˚ for the backbone atoms of the 20 best structures.
The CYANA-generated model was further refined in CNS [53],
incorporating additional dihedral angle and Zn restraints. The
CYANA assignments of the NOE peaks were checked manually.
Backbone dihedral angle restraints were derived from HN, Ha,
Ca,C b, C’ and N chemical shifts using TALOS+ [54]. The Zn
tetrahedral coordination geometry was maintained by setting the
bond length of Zn-Sc(Cys) as 2.3 A ˚ and the bond angle of Sc(Cys)-
Zn-Sc(Cys) as 109.5 degree. The Zn restraints that can be assigned
by
113Cd NMR experiments were incorporated first. Zn-C was
assigned by
113Cd NMR to be ligated to Cys558 and Cys561.
Inspection of the resulting structures suggested that Cys539 and
Cys553 are the remaining two ligands for Zn-C. Incorporation of
these two Zn-C restrains caused no NOE violations during the
structure calculation, whereas coordination of Zn-C with different
ligands caused violations around the Zn-cysteine cluster, indicating
the correctness of the assignment.
100 structures were calculated, and the 50 lowest energy
structures were further refined with electrostatic potentials and
explicit water using CNS and RECOORDScript [55]. The 20
lowest energy structures were selected for final analysis using
PROCHECK-NMR [56], MolMol [57] and WHAT_CHECK
[58]. Structural figures were created with PyMOL [59].
Accession Numbers
The NMR resonance assignments for CXC-3 have been
deposited in the BioMagResBank with accession number 18514.
The atomic coordinates and experimental NMR restraints for the
MSL2 CXC domain have been deposited in the Protein Data
Bank with accession code 2LUA.
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